Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system

BackgroundDespite the likely association between coronavirus 2019 (COVID-19) mRNA vaccines and cases of myocarditis/pericarditis, the benefit–risk assessment by the Centers for Disease Control (CDC) still showed a favorable balance for the primary series of COVID-19 mRNA vaccinations. Since August 2...

Cijeli opis

Bibliografski detalji

Glavni autori:	Congqin Chen, Fang Fu, Lingqing Ding, Jie Fang, Jie Xiao
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2022-09-01
Serija:	Frontiers in Immunology
Teme:	myocarditis pericarditis COVID-19 mRNA vaccination booster dose primary series
Online pristup:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.938322/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!